Abstract
Conventional itraconazole (C-ITZ) suffers from absorption variability. SUBA-itraconazole (S-ITZ) is more bioavailable than C-ITZ at steady state in a fed condition, but there are no data comparing the two under a fasted state. An open-label, single-dose, randomized, bioequivalence study was performed comparing S-ITZ to C-ITZ capsules under fasted and fed conditions in healthy adults measuring itraconazole and hydroxyitraconazole plasma levels. This study demonstrated less variability of S-ITZ compared to C-ITZ capsules under fasted conditions.
Original language | English |
---|---|
Article number | e00134 |
Journal | Antimicrobial agents and chemotherapy |
Volume | 65 |
Issue number | 8 |
DOIs | |
State | Published - Aug 2021 |
Keywords
- Bioavailability
- Endemic mycoses
- Itraconazole
- Pharmacokinetics